Phase I Study Approval – Negeri Sembilan Chinese Maternity Hospital (NSCMH)

Cytopeutics joined hands with NSCMH to begin a study on umbilical cord mesenchymal stem cell treatment in healthy participants. This marks the first time a private hospital in Seremban was licensed by the Health Ministry to conduct stem cell research.